• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Ipsen builds again, licensing Day One glioma drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 25, 2024 at 11:12: AM
via Ipsen has signed yet another portfolio-expanding deal – its fifth of the year so far – claiming rights outside the US to a drug for common brain cancer glioma from Day One Biopharmaceuticals.

article source
 




Top Bottom
Back
Quote